Back to news list

Medis Receives FDA 510(k) Clearance for QPlaque® MR

The US Food and Drug Administration (FDA) has provided market clearance for QPlaque MR, Medis’ software solution for the analysis of the vessel wall in multi-spectral MR studies of the carotid arteries.

This clearance of Medis’ latest solution for vascular analysis means that clinicians and researchers can now obtain reliable quantitative data to support the assessment of vessel wall condition in patients with atherosclerosis.

Read more about Medis’ QPlaque® MR